SANUWAVE Health (SNWV) CEO receives 1,540 fully vested stock options grant

Rhea-AI Filing Summary

SANUWAVE Health Chief Executive Officer Morgan C. Frank, who also serves as a director, reported receiving a new stock option award. On 12/31/2025, he was granted a stock option to buy 1,540 shares of common stock at an exercise price of $29.84 per share. The filing states that these options were fully vested at the grant date, meaning they are immediately exercisable, and they carry an expiration date of 12/31/2030. After this grant, Frank beneficially owns 1,540 derivative securities in the form of these stock options, held directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FRANK MORGAN C.

(Last) (First) (Middle)

9600 W. 76TH STREET

SUITE 118

(Street)

EDEN PRAIRIE MN 55344

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SANUWAVE Health, Inc. [ SNVW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$29.84	12/31/2025		A		1,540		(1)	12/31/2030	Common Stock	1,540	$0	1,540	D

Explanation of Responses:

1. Options were fully vested at the grant date.

	/s/ Griffin D. Foster, Attorney-in-Fact for Morgan C. Frank	01/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did SANUWAVE Health (SNWV) report for Morgan C. Frank?

The report shows that Chief Executive Officer and director Morgan C. Frank received a grant of stock options on 12/31/2025, rather than buying or selling existing shares.

How many stock options did the SANUWAVE Health (SNWV) CEO receive?

Morgan C. Frank received 1,540 stock options, each representing the right to purchase one share of SANUWAVE Health common stock.

What is the exercise price and term of the CEO’s SANUWAVE Health (SNWV) options?

The stock options have an exercise price of $29.84 per share and an expiration date of 12/31/2030, as disclosed in the filing.

When do Morgan C. Frank’s SANUWAVE Health (SNWV) options vest?

The footnote states that the options were fully vested at the grant date, so they became exercisable immediately on 12/31/2025.

How many SANUWAVE Health (SNWV) derivative securities does the CEO beneficially own after this grant?

Following the reported transaction, Morgan C. Frank beneficially owns 1,540 derivative securities, consisting of the granted stock options, held directly.

Is this SANUWAVE Health (SNWV) Form 4 filing a purchase or sale of common stock?

No common stock trade is reported; the filing discloses a grant of stock options (a derivative security) to the CEO, which gives him the right to buy shares at a set price.